Nano-SiO2 - NLRP3 Inflammasome Inducer

Silica dioxide nanoparticles

ABOUT

NLRP3 Inflammasome Inducer - Silicon Dioxid Nanoparticles

SiO2 nanoparticles (Nano-SiO2) are single particles of silica dioxide, an inorganic metal oxide, with a diameter of less than 100 nm.
Several studies have demonstrated that Nano-SiO2 trigger the NLRP3 inflammasome-dependent induction of interleukin-1β (IL-1β) and IL-18 in vitro and in vivo [1,2].

More details

 

The biological activity of Nano-SiO2  has been validated using InvivoGen's THP-1 Null cells and HEK-Blue™ IL-1β cells.

Key features:

  • Potent inducer of the NLRP3 inflammasome
  • Nanoparticles with a diameter of <100 nm
  • Each lot is functionally tested

 

Read our review on the NLRP3 inflammasome.

Download our Practical guide on Inflammasomes.

 

References:

1. Nakayama M. et al., 2018. Macrophage recognition of crystals and nanoparticles. Front Immunol. 9:103. 
2. He Y. et al., 2016. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 530(7590):354-7.

All products are for research use only, and not for human or veterinary use.

SPECIFICATIONS

Specifications

CAS number
7631-86-9
Chemical formula

SiO2

Molecular weight
60.08 g/mol
Working concentration

10-250 µg/ml

Tested applications

Cellular assays

Quality control

Biological activity validated using cellular assays, Absence of bacterial contamination (e.g. lipoproteins and endotoxins) confirmed using HEK-Blue™ TLR2 and HEK-Blue™ TLR4 cells.

CONTENTS

Contents

  • Product: 
    Nano-SiO2
  • Cat code: 
    tlrl-sio-2
  • Quantity: 
    20 mg (2 x 10 mg)

Shipping & Storage

  • Shipping method:  Room temperature
  • Storage:

    • Room temperature

Details

The NLRP3 inflammasome is an intracellular multi-protein complex that plays a central role in innate immunity. It is activated by a two-step process. A first signal (‘priming’) is provided by pathogen-associated molecular patterns (PAMPs) or cytokines. It allows the transcriptional upregulation of key inflammasome actors and the post-translational modification of NLRP3 . The second signal (‘activation’) is provided by a wide array of stimuli including microbial toxins, endogenous molecules or crystalline substances. The current paradigm is that NLRP3 does not bind directly to these molecules. Rather it senses downstream cytosolic stress signals such as K+ efflux. This  triggers inflammasome multimerization and pro-caspase-1 maturation. Proximity-induced autolytic activation of caspase-1 leads to the formation of gasdermin D (GSDMD) pores at the cell surface, allowing IL-1β/IL-18 and alarmin secretion, and ultimately, pyroptosis [1,2].

 

References:

1. Swanson K.V. et al., 2019. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 19:477.
2. Groslambert M. & Py B. 2018. Spotlight on the NLRP3 inflammasome pathway. J. Inflamm. Res. 11:359.

DOCUMENTS

Documents

Nano-SiO2

Technical Data Sheet

Safety Data Sheet

Validation Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?